References
- Skroza N, Tolino E, Mambrin A, et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol. 2018;11(1):21–25.
- Zeichner JA, Baldwin HE, Cook-Bolden FE, et al. Emerging issues in adult female acne. J Clin Aesthet Dermatol. 2017;10(1):37–46.
- Jusuf NK, Putra IB, Sari L. Differences of microbiomes found in non-inflammatory and inflammatory lesions of acne vulgaris. Clin Cosmet Investig Dermatol. 2020;13:773–780. doi:10.2147/CCID
- Zhang N, Yuan R, Xin KZ, Lu Z, Ma Y. Antimicrobial susceptibility, biotypes and phylotypes of clinical cutibacterium (formerly propionibacterium) acnes strains isolated from acne patients: an observational study. Dermatol Ther. 2019;9(4):735–746. doi:10.1007/s13555-019-00320-7
- Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190–1192. doi:10.1126/science.1171700
- Beylot C, Auffret N, Poli F, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28(3):271–278. doi:10.1111/jdv.12224
- Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133(9):2152–2160. doi:10.1038/jid.2013.21
- Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535–1541. doi:10.4049/jimmunol.169.3.1535
- Lee SE, Kim JM, Jeong SK, et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res. 2010;302(10):745–756. doi:10.1007/s00403-010-1074-z
- Melnik BC. Evidence for acne-promoting effects of milk and other insulinotropic dairy products. Milk Milk Products Human Nutrition. 2011;67:131–145.
- Mirdamadi Y, Bommhardt U, Goihl A, et al. Insulin and Insulin-like growth factor-1 can activate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in T cells in vitro. Dermato-Endocrinology. 2017;9(1):e1356518. doi:10.1080/19381980.2017.1356518
- Juhl CR, Bergholdt HK, Miller IM, et al. Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 children, adolescents, and young adults. Nutrients. 2018;10(8):1049. doi:10.3390/nu10081049
- Nast A, Dréno B, Bettoli V, et al. European evidence‐based (S3) guideline for the treatment of acne–update 2016–short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. doi:10.1111/jdv.13776
- Zhu T, Zhu W, Wang Q, et al. Antibiotic susceptibility of Propionibacterium acnes isolated from patients with acne in a public hospital in Southwest China: prospective cross-sectional study. BMJ Open. 2019;9:e022938. doi:10.1136/bmjopen-2018-022938
- Schafer F, Fich F, Lam M, et al. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Int J Dermatol. 2013;52(4):418–425. doi:10.1111/j.1365-4632.2011.05371
- Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148(3):467–478. doi:10.1046/j.1365-2133.2003.05067.x
- Alkhawaja E, Hammadi S, Abdelmalek M, et al. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. BMC Dermatol. 2020;20(1):17. doi:10.1186/s12895-020-00108-9
- Sari L, Jusuf N, Putra I. Bacterial identification of acne vulgaris. Bali Med J. 2020;9(3):753–756. doi:10.15562/bmj.v9i3.1737
- Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol. 2003;83(4):241–248. doi:10.1080/00015550310016463